Online ISSN: 3007-0244,
Print ISSN:  2410-4280
PREDICTIVE VALUE OF HEMOGRAM INDICES IN THE EVALUATION OF THE 30-DAY MORTALITY RISKS IN COVID-19 DEPENDING ON GENDER
The aim. SARS-CoV-2 infection can have a profound effect on the functioning of the immune system. Differences in the prognostic significance of hemogram indices raise the question of existing gender immunological differences. The study aims to compare the significance of the hematological indices for the evaluation of the 30-day mortality risk in men and women. Materials and methods. A retrospective observational study included 1419 patients with a positive PCR nasopharyngeal swab for COVID-19 hospitalized between 1 May 2021 and 30 August 2021 at Karaganda clinical hospital, Kazakhstan. Laboratory tests performed upon admission included a complete blood count to obtain NLR, NPR, PLR, and SII. A receiver operating characteristic curve was performed to analyze the efficiency of the prognosis of the 30-day mortality. Using univariate and multivariate Cox regression was analyzed the association of neutrophil indices with mortality. Results. In total, 95 people (8.5%) died in 30 days, the mortality rate among men was 1,9 times higher than among women. The value of SII and TLR in predicting mortality in women was AUC 0.714 and 0.624 respectively. In men, NLR had the highest AUC of 0.736. Conclusion. Elevated NLR, NPR, and SII have significant predictive value in COVID-19 mortality, especially NPR in females and NLR in males.
Lyudmila G. Turgunova1, https://orcid.org/0000-0002-6962-4247 Irina V. Mekhantseva1, https://orcid.org/0000-0001-6601-8172 Yelena M. Laryushina1, https://orcid.org/0000-0002-9590-690X Assel R. Alina1, https://orcid.org/0000-0002-3229-1506 Anar A. Turmukhambetova2, https://orcid.org/0000-0002-4668-3295 1 Karaganda Medical University, Department of Internal Medicine, Karaganda, Kazakhstan; 2 Karaganda Medical University, Department of Strategic Development and Science, Karaganda, Kazakhstan.
1. Abate S.M., Checkol Y.A., Mantefardo B. Global prevalence and determinants of mortality among patients with COVID-19: A systematic review and meta-analysis // Annals of Medicine and Surgery. 2021; 64:102204. 2. Belice T., Demir I., Yüksel A. Role of neutrophil-lymphocyte-ratio in the mortality of males diagnosed with COVID-19 // Iranian journal of microbiology. 2020; 12:194–197. 3. Channappanavar R., Fett C., Mack M., ten Eyck P.P., Meyerholz D.K., Perlman S. Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection // The Journal of Immunology. 2017; 198:4046–4053. 4. Ciarambino T., Para O., Giordano M. Immune system and COVID-19 by sex differences and age // Women’s Health. 2021; 17:174550652110222. 5. Doganci S., Ince M.E., Ors N., Yildirim A.K. et al. A new COVID-19 prediction scoring model for in-hospital mortality: experiences from Turkey, single center retrospective cohort analysis // European review for medical and pharmacological sciences. 2020; 24:10247–10257. 6. Dessie Z.G., Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients // BMC Infectious Diseases. 2021; 21:855. 7. Fois A.G., Paliogiannis P., Scano V., Cau S. et al. The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients // Molecules. 2020. 25:5725. 8. Gadi N., Wu S.C., Spihlman A.P., Moulton V.R. What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses // Frontiers in Immunology. 2020; 11. 9. Haick A.K., Rzepka J.P., Brandon E., Balemba O.B., Miura T.A. Neutrophils are needed for an effective immune response against pulmonary rat coronavirus infection, but also contribute to pathology // Journal of General Virology. 2014; 95:578–590. 10. Karimi A., Shobeiri P., Kulasinghe A., Rezaei N. Novel Systemic Inflammation Markers to Predict COVID-19 Prognosis // Frontiers in Immunology. 2021; 12. 11. Kilercik M., Demirelce Ö., Serdar M.A., Mikailova P., Serteser M. A new haematocytometric index: Predicting severity and mortality risk value in COVID-19 patients // PLOS ONE. 2021; 16:e0254073. 12. Liu Y., Du X., Chen J., Jin Y., Peng L. et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19 // Journal of Infection. 2020; 81:e6–e12. 13. López-Escobar A., Madurga R., Castellano J.M., Velázquez S. et al. Risk Score for Predicting In-Hospital Mortality in COVID-19 (RIM Score) // Diagnostics. 2021; 11:596. 14. Macedo A., Gonçalves N., Febra C. COVID-19 fatality rates in hospitalized patients: systematic review and meta-analysis // Annals of epidemiology. 2021; 57:14-21. 15. Mazzoni A., Salvati L., Maggi L., Annunziato F., Cosmi L. Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion // Seminars in Immunology. 2021; 55:101508. 16. Merad M., Martin J.C. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages // Nature Reviews Immunology. 2020; 20:355–362. 17. Nasiri M.J., Haddadi S., Tahvildari A., et al. COVID-19 Clinical Characteristics, and Sex-Specific Risk of Mortality: Systematic Review and Meta-Analysis // Front Med (Lausanne). 2020; 7:459. 18. Nguyen N.T., Chinn J., de Ferrante M., Kirby K.A., Hohmann S.F., Amin A. Male gender is a predictor of higher mortality in hospitalized adults with COVID-19 // PLOS ONE. 2021; 16:e0254066 19. Ortona E., Pierdominici M., Rider V. Editorial: Sex hor-mones and gender differences in immune responses // Front Immunol. 2019; 10:1076. 20. Peckham H., de Gruijter N.M., Raine C. et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission // Nat Commun. 2020; 11(1):6317. 21. Qi S., Ngwa C., Morales Scheihing D.A., al Mamun A. et al. Sex differences in the immune response to acute COVID-19 respiratory tract infection // Biology of Sex Differences. 2021; 12:66. 22. Sawant K., Poluri K.M., Dutta A.K., Sepuru K.M. et al. Chemokine CXCL1 mediated neutrophil recruitment: Role of glycosaminoglycan interactions // Scientific Reports. 2016; 6:33123. 23. Simadibrata D.M., Calvin J., Wijaya A.D., Ibrahim N.A.A. Neutrophil-to-lymphocyte ratio on admission to predict the severity and mortality of COVID-19 patients: A meta-analysis // The American Journal of Emergency Medicine. 2021; 42:60–69. 24. Simadibrata D.M., Pandhita B.A.W., Ananta M.E., Tango T. Platelet-to-lymphocyte ratio, a novel biomarker to predict the severity of COVID-19 patients: A systematic review and meta-analysis // Journal of the Intensive Care Society. 2022; 23:20–26. 25. Velazquez S., Madurga R., Castellano J.M., Rodriguez-Pascual J. et al. Hemogram-derived ratios as prognostic markers of ICU admission in COVID-19 // BMC Emergency Medicine. 2021; 21:89. 26. Wang X., Li X., Shang Y., Wang J. et al. Ratios of neutrophil-to-lymphocyte and platelet-to-lymphocyte predict all-cause mortality in inpatients with coronavirus disease 2019 (COVID-19): a retrospective cohort study in a single medical centre // Epidemiology and Infection. 2020; 148:e211. 27. World Health Organization. Coronavirus. https://covid19.who.int (Accessed 02.01.2023) 28. Wu Z., McGoogan J.M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China // JAMA. 2020; 323:1239. 29. Yegorov S., Goremykina M., Ivanova R., Good S., Babenko D., Shevtsov A., MacDonald K.S., Zhunussov Y. Epidemiology, clinical characteristics, and virologic features of COVID-19 patients in Kazakhstan: A nation-wide retrospective cohort study // The Lancet Regional Health – Europe. 2021; 4:100096. 30. Zhu Y., Zhang J., Li Y., Liu F., Zhou Q., Peng Z. Association between thrombocytopenia and 180-day prognosis of COVID-19 patients in intensive care units: A two-center observational study // PLOS ONE. 2021; 16:e0248671.
Количество просмотров: 292

Ключевые слова:

Категория статей: Актуальная тема COVID-19

Библиографическая ссылка

Turgunova L.G., Mekhantseva I.V., Laryushina Ye.M., Alina A.R., Turmukhambetova A.A. Predictive value of hemogram indices in the evaluation of the 30-day mortality risks in COVID-19 depending on gender // Nauka i Zdravookhranenie [Science & Healthcare]. 2023, (Vol.25) 3, pp. 7-15. doi 10.34689/SH.2023.25.3.001

Авторизируйтесь для отправки комментариев